<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00100867</url>
  </required_header>
  <id_info>
    <org_study_id>ACTG A5190-P1054</org_study_id>
    <secondary_id>1U01AI068636</secondary_id>
    <nct_id>NCT00100867</nct_id>
  </id_info>
  <brief_title>Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women</brief_title>
  <official_title>Assessment of Safety and Toxicity Among Infants Born to HIV-1-Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AIDS Clinical Trials Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>AIDS Clinical Trials Group</source>
  <brief_summary>
    <textblock>
      In clinical trials being conducted throughout the world, pregnant HIV-infected women are
      given anti-HIV drugs before, during, and after they give birth to prevent mother-to-child
      transmission of HIV. However, the effects of this anti-HIV treatment on infants is unknown.
      The purpose of this study is to determine the safety, toxicity, and potential side effects of
      maternal anti-HIV treatment on infants born to these HIV-infected women.

      Study hypothesis: Specific combination antiretroviral regimens used in clinical trials in
      diverse areas of the world are safe and well tolerated during pregnancy and breastfeeding
      periods, and are not associated with adverse side effects to the fetus, neonate, and/or
      breastfeeding infant. These regimens are associated with reduction of mother-to-child HIV
      transmission.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many HIV-infected women outside the United States enroll in clinical trials that provide them
      antiretroviral therapy (ART) to prevent mother-to-child transmission of HIV. However, data
      are limited on the safety, toxicity, and adverse effects that maternal ART may have on
      infants born to HIV-infected women. This study will monitor the adverse effects and potential
      benefits of maternal ART on these infants.

      No antiretrovirals will be given in this study. This study will last 18 months. Infants will
      be enrolled in the study within 48 hours of birth. There will be 6 study visits starting at
      study entry and every 6 weeks thereafter. Infants will undergo blood and urine collection,
      and medical history assessments will occur at every visit. Mothers will also be evaluated at
      these visits.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">236</enrollment>
  <condition>HIV Infections</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and urine collection
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Infants born to HIV-infected women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infant born to HIV-1 infected mother enrolled in NIH-sponsored, international
             antiretroviral treatment trial AND who has had either in utero or postpartum
             antiretroviral exposure

          -  Parent or guardian willing to provide informed consent

        Exclusion Criteria:

          -  Infant with no exposure to antiretrovirals OR who received only intrapartum
             antiretroviral exposure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karin Nielsen, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Judith S. Currier, MD, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Center for AIDS Research and Education, University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Gaborone BHP Study Clinic</name>
      <address>
        <city>Gaborone</city>
        <country>Botswana</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Molepolole BHP Study Clinic</name>
      <address>
        <city>Gaborone</city>
        <country>Botswana</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Pesquisa Clinica Evandro Chagas Fiocruz, Fundacao Oswaldo Cruz</name>
      <address>
        <city>Rio de Janeiro,</city>
        <zip>21045-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital dos Servidores do Estado</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>22261-161</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Geral de Nova Iguacu</name>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>YRG Center for AIDS Research and Education</name>
      <address>
        <city>Chennai</city>
        <zip>60001-7</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NARI AIDS Research Institute, Department of Clinical Science</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NARI AIDS Research Institute, Dr. Kotnis Dispensary</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NARI-NIV Clinic</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. of Malawi, John Hopkins Project</name>
      <address>
        <city>Blantyre</city>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Project (UNC Project)</name>
      <address>
        <city>Lilongwe</city>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asociacion Civil IMPACTA Salud y Educacion,</name>
      <address>
        <city>Miraflores</city>
        <state>Lima</state>
        <zip>18</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asociacion Civil IMPACTA Salud y Educacion, Lince</name>
      <address>
        <city>Lima</city>
        <zip>18</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Perinatal HIV Research Unit at Chris Baragwanath Hospital</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of the Witwatersrand</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bankok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonburi Regional Hospital, Chonburi</name>
      <address>
        <city>Muang</city>
        <state>Chonburi</state>
        <zip>20000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phayao Provincial Hospital, Phayao</name>
      <address>
        <city>Tambol Mae Sai</city>
        <state>Muang Phayao</state>
        <zip>56000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bhumibol Adulyadej Hospital, Bangkok</name>
      <address>
        <city>Bangkok</city>
        <zip>10120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiang Mai University</name>
      <address>
        <city>Chang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Recherche pour Developpement (IRD)</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prapokklao Hospital Chantaburi</name>
      <address>
        <city>Muang Chantaburi</city>
        <zip>22000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Zimbabwe</name>
      <address>
        <city>Harare</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Botswana</country>
    <country>Brazil</country>
    <country>India</country>
    <country>Malawi</country>
    <country>Peru</country>
    <country>South Africa</country>
    <country>Thailand</country>
    <country>Zimbabwe</country>
  </location_countries>
  <reference>
    <citation>Abrams EJ. Prevention of mother-to-child transmission of HIV--successes, controversies and critical questions. AIDS Rev. 2004 Jul-Sep;6(3):131-43. Review.</citation>
    <PMID>15595430</PMID>
  </reference>
  <reference>
    <citation>Scarlatti G. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. AIDS Rev. 2004 Apr-Jun;6(2):67-78. Review.</citation>
    <PMID>15332429</PMID>
  </reference>
  <reference>
    <citation>Semprini AE, Fiore S. HIV and pregnancy: is the outlook for mother and baby transformed? Curr Opin Obstet Gynecol. 2004 Dec;16(6):471-5. Review.</citation>
    <PMID>15534442</PMID>
  </reference>
  <reference>
    <citation>Sullivan JL. Prevention of mother-to-child transmission of HIV--what next? J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S67-72. Review.</citation>
    <PMID>14562860</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2005</study_first_submitted>
  <study_first_submitted_qc>January 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2005</study_first_posted>
  <last_update_submitted>March 31, 2016</last_update_submitted>
  <last_update_submitted_qc>March 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Perinatal Transmission</keyword>
  <keyword>Mother-to-Child Transmission</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

